First report of Candida auris in Guangdong, China: clinical and microbiological characteristics of 7 episodes of candidemia

References

• WHO fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• Mirhendi H, Charsizadeh A, Aboutalebian S, et al. South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature. Mycoses. 2022;65(2):134–139.
   PubMed Web of Science ®Google Scholar
• van Schalkwyk E, Mpembe RS, Thomas J, et al. Epidemiologic shift in Candidemia driven by Candida auris, South Africa, 2016-2017(1). Emerg Infect Dis. 2019;25(9):1698–1707.
   PubMed Web of Science ®Google Scholar
• Chen J, Tian S, Han X, et al. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis. 2020;20(1):827.
   PubMed Web of Science ®Google Scholar
• Ong CW, Chen SC, Clark JE, et al. Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases. Intern Med J. 2019;49(10):1229–1243.
   PubMed Web of Science ®Google Scholar
• Mathur P, Hasan F, Singh PK, et al. Five-year profile of candidaemia at an Indian trauma centre: high rates of Candida aurisblood stream infections. Mycoses. 2018;61(9):674–680.
   PubMed Web of Science ®Google Scholar
• Shastri PS, Shankarnarayan SA, Oberoi J, et al. Candida auris candidaemia in an intensive care unit - prospective observational study to evaluate epidemiology, risk factors, and outcome. J Crit Care. 2020;57:42–48.
   PubMed Web of Science ®Google Scholar
• Sanyaolu A, Okorie C, Marinkovic A, et al. Candida auris: an overview of the emerging drug-resistant fungal infection. Infect Chemother. 2022;54(2):236–246.
   PubMed Web of Science ®Google Scholar
• Chow NA, de Groot T, Badali H, et al. Potential fifth clade of candida auris, Iran, 2018. Emerg Infect Dis. 2019;25(9):1780–1781.
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134–140.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Alfouzan W. Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms. 2021;9(4).
   Web of Science ®Google Scholar
• Du H, Bing J, Nobile CJ, et al. Candida aurisinfections in China. Virulence. 2022;13(1):589–591.
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Prakash A, Sharma C, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018;73(4):891–899.
   PubMed Web of Science ®Google Scholar
• Spruijtenburg B, Badali H, Abastabar M, et al. Confirmation of fifth Candida aurisclade by whole genome sequencing. Emerg Microbes Infect. 2022;11(1):2405–2411.
   PubMed Web of Science ®Google Scholar
• Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China: clinical and biological aspects. Emerg Microbes Infect. 2018;7(1):93.
   PubMed Web of Science ®Google Scholar
• Salah H, Sundararaju S, Dalil L, et al. Genomic epidemiology of candida auris in Qatar reveals hospital transmission dynamics and a South Asian origin. J Fungi (Basel). 2021;7(3).
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; third information supplement. CLSI document M27-A3. CLSI, Wayne, PA, 2008.
   Google Scholar
• AlJindan R, AlEraky DM, Mahmoud N, et al. Drug resistance-associated mutations in ERG11 of multidrug-resistant candida auris in a tertiary care hospital of eastern Saudi arabia. J Fungi (Basel). 2020;7(1).
   PubMedGoogle Scholar
• Simitsopoulou M, Chatzimoschou A, Roilides E. Biofilms and antifungal susceptibility testing. Methods Mol Biol. 2016;1356:183–197.
   PubMedGoogle Scholar
• Sherry L, Ramage G, Kean R, et al. Biofilm-Forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis. 2017;23(2):328–331.
   PubMed Web of Science ®Google Scholar
• Szekely A, Borman AM, Johnson EM. Candida auris isolates of the southern Asian and South African lineages exhibit different phenotypic and antifungal susceptibility profiles In vitro. J Clin Microbiol. 2019;57(5).
   PubMed Web of Science ®Google Scholar
• Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen candida auris and other Key pathogenic candida species. mSphere. 2016;1(4).
   PubMed Web of Science ®Google Scholar
• Govender NP, Magobo RE, Mpembe R, et al. Candida aurisin South Africa, 2012–2016. Emerg Infect Dis. 2018;24(11):2036–2040.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang L, Han R, et al. A candidemia case caused by a novel drug-resistant candida auris with the Y132F mutation in Erg11 in mainland China. Infect Drug Resist. 2023;16:3065–3072.
   PubMed Web of Science ®Google Scholar
• Chow NA, Gade L, Tsay SV, et al. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. Lancet Infect Dis. 2018;18(12):1377–1384.
   PubMed Web of Science ®Google Scholar
• Ruiz GA, Moret A, Lopez HJ, et al. Nosocomial fungemia by Candida auris: first four reported cases in continental Europe. Rev Iberoam Micol. 2017;34(1):23–27.
   PubMed Web of Science ®Google Scholar
• Adam RD, Revathi G, Okinda N, et al. Analysis of Candida auris fungemia at a single facility in Kenya. Int J Infect Dis. 2019;85:182–187.
   PubMed Web of Science ®Google Scholar
• Koleri J, Petkar HM, Rahman SASH, et al. Candida auris Blood stream infection- a descriptive study from Qatar. BMC Infect Dis. 2023;23(1):513.
   PubMed Web of Science ®Google Scholar
• Simon SP, Li R, Silver M, et al. Comparative Outcomesof candida aurisbloodstream infections: a multicenter retrospective case-control study. Clin Infect Dis. 2023;76(3):e1436–e1443.
   PubMed Web of Science ®Google Scholar
• Calvo B, Melo AS, Perozo-Mena A, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016;73(4):369–374.
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Anil KV, Sharma C, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014;33(6):919–926.
   PubMed Web of Science ®Google Scholar
• Mulet BJ, Tormo PN, Salvador GC, et al. Candida auris from colonisation to candidemia: a four-year study. Mycoses. 2023;66(10):882–890.
   PubMed Web of Science ®Google Scholar
• Ortiz-Roa C, Valderrama-Rios MC, Sierra-Umana SF, et al. Mortality caused by candida auris bloodstream infections in comparison with other candida species, a multicentre retrospective cohort. J Fungi (Basel). 2023;9(7).
   PubMedGoogle Scholar
• Garcia-Bustos V, Salavert M, Ruiz-Gaitan AC, et al. A clinical predictive model of candidaemia by Candida auris in previously colonized critically ill patients. Clin Microbiol Infect. 2020;26(11):1507–1513.
   PubMed Web of Science ®Google Scholar
• Briano F, Magnasco L, Sepulcri C, et al. Candida auris candidemia in critically Ill, colonized patients: cumulative incidence and risk factors. Infect Dis Ther. 2022;11(3):1149–1160.
   PubMed Web of Science ®Google Scholar
• Rudramurthy SM, Chakrabarti A, Paul RA, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017;72(6):1794–1801.
   PubMed Web of Science ®Google Scholar
• Bing J, Wang S, Xu H, et al. A case ofCandida auriscandidemia in Xiamen, China, and a comparative analysis of clinical isolates in China. Mycology. 2022;13(1):68–75.
   PubMedGoogle Scholar
• Sharma C, Kumar N, Pandey R, et al. Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation. New Microbes New Infect. 2016;13:77–82.
   PubMedGoogle Scholar
• Chen Y, Zhao J, Han L, et al. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China. J Infect. 2018;77(6):561–571.
   PubMed Web of Science ®Google Scholar
• Tsai YT, Lu PL, Tang HJ, et al. The first invasiveCandida aurisinfection in Taiwan. Emerg Microbes Infect. 2022;11(1):1867–1875.
   PubMed Web of Science ®Google Scholar
• Oladele R, Uwanibe JN, Olawoye IB, et al. Emergence and genomic characterization of multidrug resistant candida auris in Nigeria, West Africa. J Fungi (Basel). 2022;8(8).
   Google Scholar
• Alatoom A, Sartawi M, Lawlor K, et al. Persistent candidemia despite appropriate fungal therapy: first case of Candida auris from the United Arab Emirates. Int J Infect Dis. 2018;70:36–37.
   PubMed Web of Science ®Google Scholar
• Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by candida auris. J Clin Microbiol. 2011;49(9):3139–3142.
   PubMed Web of Science ®Google Scholar
• Mulet-Bayona JV, Salvador-Garcia C, Tormo-Palop N, et al. Recurrent candidemia and isolation of echinocandin-resistant Candida auris in a patient with a long-term central catheter. Enferm Infecc Microbiol Clin (Engl Ed). 2022;40(6):334–335.
   PubMedGoogle Scholar
• Ohashi Y, Matono T, Suzuki S, et al. The first case of clade I Candida auris candidemia in a patient with COVID-19 in Japan. J Infect Chemother. 2023;29(7):713–717.
   PubMed Web of Science ®Google Scholar
• Vaseghi N, Sharifisooraki J, Khodadadi H, et al. Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida aurisinfections (CACa): A systematic review and meta-analysis. Mycoses. 2022;65(7):683–703.
   PubMed Web of Science ®Google Scholar
• Rodrigues LS, Gazara RK, Passarelli-Araujo H, et al. First genome sequences of two multidrug-resistant candida haemulonii var. vulnera isolates from pediatric patients With candidemia. Front Microbiol. 2020;11:1535.
   PubMed Web of Science ®Google Scholar
• Gomez-Gaviria M, Ramirez-Sotelo U, Mora-Montes HM. Non-albicans candida species: immune response, evasion mechanisms, and New plant-derived alternative therapies. J Fungi (Basel). 2022;9(1).
   PubMedGoogle Scholar
• Vitiello A, Ferrara F, Boccellino M, et al. Antifungal drug resistance: an emergent health threat. Biomedicines. 2023;11(4).
   Web of Science ®Google Scholar
• Jangir P, Kalra S, Tanwar S, et al. Azole resistance in Candida auris: mechanisms and combinatorial therapy. APMIS. 2023;131(8):442–462.
   PubMed Web of Science ®Google Scholar
• Forsberg K, Woodworth K, Walters M, et al. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. Med Mycol. 2019;57(1):1–12.
   PubMed Web of Science ®Google Scholar
• Tian S, Bing J, Chu Y, et al. Genomic epidemiology of Candida aurisin a general hospital in Shenyang, China: a three-year surveillance study. Emerg Microbes Infect. 2021;10(1):1088–1096.
   PubMed Web of Science ®Google Scholar
• Khari A, Biswas B, Gangwar G, et al. Candida auris biofilm: a review on model to mechanism conservation. Expert Rev Anti Infect Ther. 2023;21(3):295–308.
   PubMed Web of Science ®Google Scholar
• Ajetunmobi OH, Badali H, Romo JA, et al. Antifungal therapy of Candida biofilms: past, present and future. Biofilm. 2023;5:100126.
   PubMedGoogle Scholar
• Singh R, Kaur M, Chakrabarti A, et al. Biofilm formation by Candida aurisisolated from colonising sites and candidemia cases. Mycoses. 2019;62(8):706–709.
   PubMed Web of Science ®Google Scholar